KDKunal Dhankhar

Kunal Dhankhar

*This is an algorithmically generated author record based on publicly available information.

Kunal Dhankhar has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Beyond structure and activity: targeting class A carbapenemases with monocyclic and bicyclic boronic acids to counter antimicrobial resistance

    by Kunal Dhankhar, Mousumi Hazra, Adwaita S. R. Nair, Alaa Eddin Alhmeidi Alkhatib, Narayan C. Mishra, Saugata Hazra

    Bicyclic boronic acids inhibit SME-1 carbapenemase via a unique π–π stacking with His105 and covalent interaction with Ser70.


  • Decoding Ceftazidime-Avibactam Resistance in Newly Identified Klebsiella pneumoniae Carbapenemase (KPC) 107 Variant by Modulating the Active Site Environment

    by Riya Karan, Kunal Dhankhar, Adarsh Singh, Saroj Kumar Panda, Tanmoy Sen, Parth Sarthi Sen Gupta, Saugata Hazra

    Antibiotic resistance is a serious health concern worldwide, predominantly driven by β-lactamase enzymes that can inactivate most prescribed β-lactam drugs. Carbapenemases are specialized β-lactamases that hydrolyze carbapenems, considered last-resort antibiotics. Insertion variants of Klebsiella pneumoniae carbapenemase (KPC) play a major role in this threat, showing alarming resistance to ceftazidime-avibactam (CZA), a key combination therapy to treat this menace. KPC-107 is a variant with an exceptional 28-residue insertion raised by duplication mutation (Ser-Ser-Pro-Arg-Ala-Val-Thr-Glu-Ser-Leu-Gln-Lys-Leu-Thr-Leu-Gly-Ser-Ala-Leu-Ala-Ala-Pro-Gln-Arg-Gln-Gln-Phe-Val) between Ambler positions 180 and 181, conferring resistance to CZA. Our study employs comprehensive biophysical, biochemical, and biological analyses accompanied by molecular docking and MD simulations, reporting that KPC-107 exhibits 10 times enhanced catalytic efficiency and 4-fold increased MIC value for ceftazidime compared to KPC-2, while its activity against other tested β-lactams is diminished. The reduced Ki value (0.23 ± 0.05 μM) of avibactam against KPC-107, in contrast with KPC-2 (Ki = 0.83 ± 0.1 μM), is further explained by carbamylation and decarbamylation rates. Insertion-induced active site modification might lead to a better binding with ceftazidime, which is reduced in the case of avibactam, which could possibly explain the contrasting behavior of KPC-107 against these ligands, as confirmed by fluorescence spectroscopy and isothermal titration calorimetry (ITC). Molecular docking and MD simulations, including free energy landscape (FEL), principal component analysis (PCA), and radial distribution function (RDF), may further support the binding affinity and the mechanisms underlying ceftazidime resistance. Our findings suggest that KPC-107 adapts distinct mechanistic strategies to evade CZA armor by enhanced ceftazidime hydrolysis while compromising increased inhibition by avibactam, strengthening its role in antibiotic resistance evolution.


  • IITRS: A Promiscuous Enzyme Synchronizing β-Lactamase with Esterase

    by Abirlal Mukherjee, Jyoti Barman, Rajsekhar Adhikary, Kunal Dhankhar, Sourya Bhattacharya, Niteesh Kumar Pandey, Ayushi Singh, Saugata Hazra

    This study reveals dual catalytic activities (β-lactamase and esterase) in a new penicillin-recognizing protein (IITRS), found in two closely related species, Enterococcus faecium and Enterococcus lactis. IITRS is distinct from other β-lactamase classes, showing only limited structural and functional similarity to class C β-lactamases. The conserved KTG motif, which helps in substrate recognition in class C, is not present in this enzyme. The enzyme is different from class C in terms of different conserved loops, such as R2 and Ω loops, which are involved in the recognition, specificity, and hydrolysis of β-lactams. Nevertheless, the involvement of Ser64 and Tyr150 residues in β-lactam hydrolysis as found in class C enzymes has been demonstrated by site-directed mutagenesis. The study also highlights Tyr150 from the catalytic triad Tyr-Asp-Lys as being responsible for the esterase activity. This dual functionality confers catalytic promiscuity, enabling IITRS to function through two different mechanisms. The enzyme exhibits hydrolysis of p-NP esters (acetate, butyrate, hexanoate, decanoate, and laurate) displaying progressively higher activity with increasing alkyl chain lengths. Since Tyr150 has been found as a common ligand-binding residue for both of the activities, the β-lactamase inhibition by diisopropyl fluorophosphate (DFP), a reported inhibitor of bacterial esterase, also has been demonstrated. This promising albeit unexplored biocatalyst also might be used in the production of chiral compounds, investigating its enantioselective nature similar to other bacterial esterases. Overall, this research upholds a new promiscuous enzyme and proposes a distinct active site, narrower than that of a β-lactamase and wider than that of an esterase.

  • Structural Insights into the Role of the Stereochemistry of the Cyclopropyl Ring in the Inhibitory Activity of Xeruborbactam against SME-1 Class A Carbapenemase

    by Kunal Dhankhar, Adwaita S R Nair, Mousumi Hazra, Alaa Eddin Alhmeidi Alkhatib, Subhecchha Baidya, Narayan C Mishra, Saugata Hazra

    Xeruborbactam is a boronic acid-based transition-state analogue that has exhibited great potential as a clinically relevant inhibitor of carbapenemase enzymes, including class A carbapenemases. In this work, we have investigated the mechanism of inhibition of xeruborbactam against SME-1 carbapenemase using kinetic, structural, and thermodynamic approaches. With a Ki(app) of 4 nM, xeruborbactam shows more potent inhibitory activity than any other beta-lactamase inhibitor available until now. Structural data from crystal complexes revealed that xeruborbactam covalently engages Ser70 at the active site and forms stabilizing interactions; in particular, the cyclopropyl group forms hydrophobic interactions with His105, further stabilizing the adduct, which correlates with a high rate of borylation and minimal deborylation. We investigated xeruborbactam with its 2R,3S-cyclopropyl isomer to grasp the influence of the stereochemistry of the cyclopropyl ring. Although both inhibitors bind covalently to Ser70 in SME-1, the 2R,3S-isomer adopts a different conformation of the cyclopropyl ring, which makes the C3 carbon much farther from His105, Asn132, and Lys73, thereby decreasing the binding affinity and Ki(app) of the isomer. Furthermore, the fluorine-12 atom takes different conformations in the two structures, changing the terrain of interaction with the protein. Consistent with its lowered inhibition efficiency, the 2R,3S-isomer shows a lower borylation rate and weaker enzyme-inhibitor binding. In the molecular dynamics, xeruborbactam stabilized SME-1 more than its isomer, which is consistent with our experimental findings. These results together show the strong inhibitory profile of xeruborbactam and highlight the importance of stereochemistry in the design of next-generation β-lactamase inhibitors and diagnostics for AMR.


  • Open Access

    Physicochemical Characterisation of Commercially Available Prussian Blue Insoluble Samples and Its Comparison with Radiogardase Cs

    by Vivek Kumar, Mahendra Yadav, Kunal Dhankhar, Dharam Pal Pathak, Nidhi Sandal

    The physicochemical properties of insoluble Prussian blue (PB) play an important role in its thallium binding ability. Therefore, the present study aimed to characterise various physicochemical parameters of PB available commercially and compare them with the USFDA-approved Radiogardase ® -Cs. In addition, PB was synthesised by indirect and direct methods. PB samples and Radiogardase®-Cs were analysed for various parameters like particle size, moisture content, and thermogravimetric analysis (TGA) and correlated with its Maximum Binding Capacity (MBC) for thallium. Radiogardase ® -Cs showed the highest MBC of 238 mg/g for thallium with D 90 of 785 μm and moisture content of 23.24 %. The MBC of other PB samples was found to be significantly lower than Radiogardase ® -Cs which was found to be directly proportional to the moisture content. However, other parameters like particle size, and iron content vary significantly but no correlation was observed with MBC for thallium. This finding suggests that moisture content and MBC are extremely important parameters for optimising the PB to achieve desirable pharmacological efficacy for removing thallium in vivo.